Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Zinc modulates GABAB binding in rat brain.

S M Turgeon1, R L Albin

  • 1Neuroscience Program, University of Michigan, Ann Arbor.

Brain Research
|November 20, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Body Composition, Falls, and Freezing of Gait in Parkinson's Disease: Gender-Specific Effects.

The Journal of frailty & aging·2024
Same author

Correction to: Noradrenergic cardiac denervation is associated with gait velocity in Parkinson disease: a dual ligand PET study.

European journal of nuclear medicine and molecular imaging·2024
Same author

Noradrenergic cardiac denervation is associated with gait velocity in Parkinson disease: a dual ligand PET study.

European journal of nuclear medicine and molecular imaging·2024
Same author

Cardiac sympathetic denervation and anxiety in Parkinson disease.

Parkinsonism & related disorders·2024
Same author

Predicting Progression from Normal to MCI and from MCI to AD Using Clinical Variables in the National Alzheimer's Coordinating Center Uniform Data Set Version 3: Application of Machine Learning Models and a Probability Calculator.

The journal of prevention of Alzheimer's disease·2023
Same author

Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease.

Parkinsonism & related disorders·2016
Same journal

IGFBP3 and UBE2C are associated with protein modification pathways and serve as prognostic markers in glioma.

Brain research·2026
Same journal

Targeting neurodevelopmental miR132-3p promotes neuroprotection and axon regeneration after optic nerve injury in mice.

Brain research·2026
Same journal

Variability in acoustic startle response and prepulse inhibition across adulthood in Fragile X messenger ribonucleoprotein 1 knockout mice.

Brain research·2026
Same journal

Transcriptome-guided modeling reveals insulin-related metabolic dysfunction in SCA3 mouse cerebellum.

Brain research·2026
Same journal

Intranasal stromal cell-derived factor-1α mitigates parkinsonian deficits via dual modulation of neuroinflammation and gut microbiota in MPTP-induced models.

Brain research·2026
Same journal

Emotions, the amygdala, and the right hemisphere.

Brain research·2026
See all related articles

Zinc chloride (ZnCl2) non-competitively inhibits GABAB receptor binding at higher concentrations. Zinc modulates GABAB binding in a biphasic manner, suggesting a neuromodulatory role in the central nervous system.

Area of Science:

  • Neuroscience
  • Neurochemistry
  • Pharmacology

Background:

  • The central nervous system utilizes various neurotransmitters for signaling.
  • Gamma-aminobutyric acid (GABA) is a primary inhibitory neurotransmitter.
  • The role of trace elements like zinc in neurotransmission is an area of active research.

Purpose of the Study:

  • To investigate the effects of zinc chloride (ZnCl2) on gamma-aminobutyric acid (GABA) binding to GABAA and GABAB receptors.
  • To determine the specific mechanisms and sites of action for zinc modulation of GABAergic binding.
  • To explore the potential neuromodulatory role of zinc in the central nervous system.

Main Methods:

  • Receptor autoradiography was employed to quantify [3H]GABA binding.
  • Experiments were conducted using varying concentrations of zinc chloride (ZnCl2).

Related Experiment Videos

  • The influence of calcium concentrations on zinc's effect was also assessed.

    • Main Results:

    • Zinc non-competitively inhibited GABAB binding in a dose-dependent manner at concentrations above 100 microM.
    • Zinc did not significantly inhibit GABAA binding, ruling out non-specific effects.
    • Calcium enhanced GABAB binding but did not abolish zinc-induced inhibition, indicating distinct binding sites.
    • Zinc exhibited biphasic modulation of GABAB binding, enhancing it in specific brain regions like the hippocampus and cerebellum at lower concentrations (10-100 microM).

    Conclusions:

    • Zinc chloride (ZnCl2) acts as a neuromodulator of GABAB receptors in the central nervous system.
    • Zinc's inhibitory effect on GABAB binding is concentration-dependent and non-competitive.
    • Zinc and calcium exert their modulatory effects on GABAB binding through separate mechanisms.
    • The findings support a significant role for zinc in regulating GABAergic neurotransmission.